[VIRTUAL] PO399: Outcomes From the Prospective IDEAL Registry Study: Results Achieved With the 0.2 μg/Day FAc Implant

Iluvien (fluocinolone acetonide) - Alimera Sci, EyePoint Pharma

https://aaommg.apprisor.org/apsSession.cfm?id=PO399

Ramin Khoramnia, MD; Gerd U Auffarth MD; Frank H Koch MD; Focke Ziemssen MD

Nov 11, 2020